Clinical effect of Vasa Khanda Kushmanda Avaleha and Shunthi Khanda on Acidity Shunthi Khanda acts on Hypoacidity and Khanda Kushmanda Avaleha acts on Hyperacidity and both are in granules form

A CLINICAL STUDY TO EVALUATE THE ROLE OF DOSHIK PREDOMINANCE IN THE MANAGEMENT OF AMLAPITTA

Status

Recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2011/09/002003

Enrollment

Registered

2011-09-13

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients suffering from cardinal sign and symptoms of Amlapitta as mentioned in Ayurvedic classics like Acid indigestion Heart burn Eructation Nausea Regurtitatiuon Vomiting Lassitude

Interventions

Intervention1: Shunthi Khanda: 5 g BD for 30 days Control Intervention1: Vasa Khanda Kushmandaka Avaleha: 5 g BD for 30 days

Eligibility

Inclusion criteria

Inclusion criteria: Presence of Pratyatmaka Laksanas of Amlapitta Chronicity- more than 3 months duration

Exclusion criteria

Exclusion criteria: Chronicity of the disease less than 3 months Patients with Peptic Ulcer Duodenal Ulcer CA Stomach Cardiac disorders. Taking medicines for any other diseases like Hypertension Diabetes Mellitus Ischemic Heart Diseases Chronic Renal Failure

Design outcomes

Primary

Measure	Time frame
Roga bala ( severity of disease) Agni bala ( power of digestion) Deha bala ( strength of the body) and Chetas bala ( mental strength) Brief Psychiatric rating scale Subjective and objective signs and symptomsTimepoint: Assessment will be done on every week based on scoring of cardinal symptoms	—

Secondary

Measure	Time frame
exacerbations in signs and symptomsTimepoint: 1 week	—

Countries

India

Contacts

Public ContactDr Kuntal Ghosh

IPGT and RA

baghelayu@rediffmail.com09427207964

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026